Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors

Clinical trial NCT03114319 · TERMINATED

Trial details

NCT number: NCT03114319
Sponsor: Novartis Pharmaceuticals
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced EGFR Mutant Non Small Cell LungCancer (NSCLC)KRAS G12-mutant NSCLC Esophageal Squamous Cell Cancer (SCC)Head/Neck SCC Melanoma Advanced Gastrointestinal Stromal Tumors (GIST)Advanced NRAS/BRAFT wt Cutaneous Melanoma

Start date: 2017-05-26
Primary completion: 2025-07-04
Enrollment: 227

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.